Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database
Saliba, Layla, Moulis, Guillaume, Abou Taam, Malak, Rousseau, Vanessa, Chebane, Leila, Petitpain, Nadine, Baldin, Bernadette, Pugnet, Grégory, Montastruc, Jean-Louis, Bagheri, HalehVolume:
30
Language:
english
Journal:
Fundamental & Clinical Pharmacology
DOI:
10.1111/fcp.12171
Date:
April, 2016
File:
PDF, 1.30 MB
english, 2016